NIOX Group (LON:NIOX) Issues Quarterly Earnings Results

NIOX Group (LON:NIOX) announced its quarterly earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.37% and a return on equity of 10.14%.

NIOX Group Stock Up 1.5%

Shares of LON:NIOX traded up GBX 1 during mid-day trading on Wednesday, hitting GBX 69. 722,177 shares of the company traded hands, compared to its average volume of 803,558. The stock has a 50-day moving average price of GBX 65.54 and a two-hundred day moving average price of GBX 61.58. NIOX Group has a 12-month low of GBX 53.84 and a 12-month high of GBX 76. The stock has a market cap of £290.40 million, a P/E ratio of 42.07 and a beta of 0.92. The company has a current ratio of 3.81, a quick ratio of 1.94 and a debt-to-equity ratio of 1.36.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.